Physician profile
Andrew Silman
NPI 1780388504
$4,634.69
in general payments reported to CMS, 2019-2025
10 companies · $3,551 in 2025
The $3,551 reported for 2025 was more than what 97% of providers received nationally.
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2024: $1,084 · 2025: $3,551.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,365 · Travel and Lodging: $1,269.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,365.22 |
| Travel and Lodging | $1,269.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Stryker Corporation | $3,436.44 | 2024-2025 | Prostep, Prostep Mica, Infinity |
| International Life Sciences | $226.34 | 2024 | Flexband |
| Smith+Nephew, INC. | $210.12 | 2025 | Stravix, Collagenase Santyl |
| Depuy Synthes Sales INC. | $209.50 | 2025 | Motoband, Na |
| Lightbody Medical Technologies INC | $202.58 | 2024-2025 | |
| Organogenesis INC. | $145.59 | 2025 | Puraply Wound Matrix |
| Mimedx Group, INC. | $123.04 | 2025 | |
| Orthofix Medical, INC. | $39.14 | 2024 | Truelok System, Truelok |
| Zimmer Biomet Holdings, INC. | $22.40 | 2025 | Tapestry |
| Urgo Medical North America, LLC | $19.54 | 2025 | Vashe Wound Solution 250 Ml (8.5 Fl Oz) Flip Top Cap |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Andrew Silman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.